M&A Deal Summary

Phadia AB Acquires Allergon AB

On January 1, 1971, Phadia AB acquired life science company Allergon AB

Acquisition Highlights
  • This is Phadia AB’s 1st transaction in the Life Science sector.
  • This is Phadia AB’s 1st transaction in Sweden.

M&A Deal Summary
Date 1971-01-01
Target Allergon AB
Sector Life Science
Buyer(s) Phadia AB
Deal Type Add-on Acquisition

Target

Allergon AB

Ängelholm, Sweden
Allergon AB is a Swedish company that will become a world's major producer of allergen source material and a cornerstone in Pharmacia Diagnostics’ allergy tests.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Phadia AB

Uppsala, Sweden
Category Company
Founded 2004
Sector Healthcare Services
Revenue 380M EUR (2013)
DESCRIPTION

Phadia AB,a provider in in-vitro allergy diagnostics and the European leader in autoimmunity diagnostics. It has a global footprint, distributing directly in 21 territories and enjoying further reach through a broad international network of distributors. The company is headquartered in Uppsala, Sweden, and employs over 1,100 people worldwide.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Sweden) 1 of 1
Year (1971) 1 of 1
Mergr

Product

Company

Legal